Background: The advances in medicine have led to improved survival rates for children diagnosed with cancer. Despite these improvements, late mortality rates for cancer survivors exceed those of the general population. Leading causes of death in this population include subsequent cancer, followed by pulmonary and cardiovascular events.
Diabetic nephropathy is the most important cause of increased morbidity and premature mortality in patients with type 1 diabetes mellitus. Detection of microalbuminuria helps to carry out early interventions to halt the progression of early stages of diabetic nephropathy to advanced renal disease. In this study the albumin: creatinine ratio was estimated in 70 children and adolescents with type 1 diabetes mellitus and 74 non-diabetic subjects attending Basrah Maternity and Children Hospital over one-year period (from the first of June 2001 till the end of May 2002), their ages ranged from 16 month-18 year. Albumin: creatinine ratio on early morning urine samples, HbA1C, blood pressure measurements and growth measures were recorded. Microalbuminuria (albumin: creatinine ratio 30-300mg/g) was present in 41.42% of patients with type 1 diabetes mellitus, while macroalbuminuria (albumin: creatinine ratio > 300mg/g) was detected in one patient (1.42%). Factors associated with a raised albumin: creatinine ratio compared with normoalbuminuric patients (albumin: creatinine ratio < 30 mg/g) with type 1 diabetes mellitus include longer duration of diabetes mellitus (P-value < 0.01), poor glycemic control reflected by raised HbA1C (P-value <0.001), and older age of diabetic patients (P-value <0.05). Microalbuminuria was not associated with body mass index, gender and systolic and diastolic blood pressure. These results stress the need for routine monitoring of diabetic patients for microalbuminuria and the importance of improved glycemic control in these patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.